Skip to main content
A

Alphasip

Alphasip provides the MedBox PneumoSIP platform, a compact 3‑in‑1 device that integrates automated sample extraction, thermocycling and data analysis to perform universal PCR assays without the need for a biosafety cabinet or specialized staff. The system delivers multiplex molecular results in as little as 19 minutes, reducing contamination risk, human error and operational costs for hospitals, point‑of‑care labs and other diagnostic users.

Madrid, SpainFounded 2007142K+ followers
Updated 2 months ago

Funding

$3.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

E
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Healthcare providers often lack rapid, low‑cost molecular diagnostic tools that can be operated outside specialized laboratory environments, leading to delayed detection of antibiotic‑resistant infections and other pathogens. The need for clean rooms, trained microbiology staff, and extensive consumables limits testing capacity at point‑of‑care locations.

Solution

Alphasip offers the MedBox PneumoSIP platform, a compact, integrated system that combines automated sample extraction, thermocycling, and data analysis in a single 3‑in‑1 device. The platform uses a universal PCR workflow that can be performed by non‑expert users without a biosafety cabinet, reducing contamination risk and human error. Its multiplex capability supports up to six channels, enabling simultaneous detection of multiple targets such as drug‑resistant bacteria or viral pathogens. By eliminating the need for separate equipment and clean‑room infrastructure, MedBox delivers results in as little as 19 minutes, facilitating timely clinical decisions and lowering operational costs. The system is designed for scalability across sectors, with customizable cartridge formats for applications in human health, veterinary diagnostics, food safety, and defense.

Target Audience

Primary customers are hospitals, clinical laboratories, and point‑of‑care facilities that require fast, multiplex molecular testing, as well as research institutes and industry partners developing diagnostics for antimicrobial resistance, infectious diseases, and related fields.

Features

  • Integrated robot extractor, thermocycler, and computing unit in a single portable device
  • Universal PCR protocol usable by non‑expert personnel without a biosafety cabinet
  • Multiplex testing with six independent channels and semi‑random access to assays
  • Rapid turnaround time (UltraFastPCR) delivering results in 19 minutes
  • Reduced risk of cross‑contamination and patient ID errors through automated workflow
  • Scalable cartridge design for DNA/RNA detection across clinical, veterinary, and food safety applications
  • Compatibility with existing laboratory information systems via standard data export formats
This profile is AI-generated and may contain inaccuracies.